Распространенность и лечение недементных когнитивных расстройств в пожилом возрасте

1. Артемьев Д.В., Захаров В.В., Левин О.С. и др. Старение и нейродегенеративные расстройства: когнитивные и двигательные нарушения в пожилом возрасте. М., 2005.
2. Дамулин И.В. Болезнь Альцгеймера и сосудистая деменция. Под ред. Н.Н.Яхно. М., 2002.
3. Дамулин И.В., Захаров В.В., Яхно Н.Н. Когнитивные нарушения: дифференциальная диагностика и методы лечения. Методические рекомендации. М., 2000.
4. Захаров В.В. Всероссийская программа исследований эпидемиологии и терапии когнитивных расстройств в пожилом возрасте («Прометей»). Неврол. журн. 2006; 11: 27–32.
5. Захаров В.В. Распространенность и лечение когнитивных нарушений в неврологической клинике (Результаты Всероссийского исследования «Прометей»). Consilium Medicum 2007; 10 (2): 25–9.
6. Захаров В.В., Локшина А.Б. Применение препарата «Проноран» (пирибедил) при легких когнитивных расстройствах у пожилых больных с дисциркуляторной энцефалопатией. Неврол. журн. 2004; 2: 30–5.
7. Захаров В.В., Ярославцева Н.В., Яхно Н.Н. Когнитивные нарушения при болезни Паркинсона. Неврол. журн. 2003; 2: 11–6.
8. Захаров В.В., Яхно Н.Н. Когнитивные расстройства в пожилом и старческом возрасте. Методическое пособие для врачей. М., 2005.
9. Локшина А.Б. Легкие и умеренные когнитивные расстройства при дисциркуляторной энцефалопатии. Дис. ... канд. мед. наук. М., 2005.
10. Локшина А.Б., Захаров В.В. Легкие и умеренные когнитивные расстройства при дисциркуляторной энцефалопатии. Неврол. журн. 2006; 11 (Приложение 1): 57–64.
11. Мхитарян Э.А. Значение сосудистых церебральных нарушений при болезни Альцгеймера. Дис. канд. мед. наук. М., 2004.
12. Обухова А.В. Применение селективного агониста D2/D3-дофаминовых рецепторов Пронорана (пирибедила) при терапии болезни Паркинсона. Неврол. журн. 2002; 3: 38–40.
13. Чарвей А. Когнитивный вызванный потенциал Р 300 у пациентов с легкими и умеренными когнитивными расстройствами и у пациентов с дисциркуляторной энцефалопатией. Дис. канд. мед. наук. М., 2006.
14. Яхно Н.Н. Когнитивные расстройства в неврологической клинике. Неврол. журн. 2006; 11 (Приложение 1): 4–12.
15. Яхно Н.Н., Захаров В.В. Легкие когнитивные нарушения в пожилом возрасте. Неврол. журн. 2004; 1: 4–8.
16. Artero S, Tierney MC, Touchon MС et al Prediction of transition from cognitive impairment to senile dementia: a prospective longitudinal study. Acta Psych Scand 2003; 107: 390–3.
17. Aston-Jones G, Rajkowsky J, Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiat 1999; 46: 1309–20.
18. Bäckman L, Ginovant N, Dixon R et al. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiat 1999; 46: 1309–20.
19. Bartoli G, Wichrowska E. Controlled clinical trial of piribedil in the treatment of cerebrovascular insufficiency. La Clin Ter 1976; 78 (2): 141–51.
20. Bennett DA, Wilson RS, Schneider JA et al Natural history of mild cognitive impairment in older persons. Neurology 2002; 59 (2): 13–26.
21. Bille J, Bukiwsky JV, De Ferron A et al Decline cerebral et therapeutique: une etude clinique multicenrique de Trivastal 50 retard en Neuro-Geriatrie. Psych Med 1986; 18: 609–26.
22. Bischkoph J, Busse A, Argermeyer MC. Mild cognitive impairment – a review of prevalence, incidence and outcome according to current approaches. Acta Psych Scand 2002; 106 (6): 403–10.
23. Boeve B, McCormick J, Smith G et al Mild cognitive impairment in the oldest old. Neurology 2003; 60 (3): 21–7.
24. Bowler JB, Hachinski VC. Vascular cognitive impairment: a new approach to vascular dementia. In: cerebrovascular disease. V.Hachinski, Ed.: Balliere Tindall. London, 1995; 357–76.
25. Brown W, Moody DM, Thore CR et al. Cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci 2002; 76–81.
26. Burns A, Zaudig M. Mild cognitive impairment in older people. The Lancet 2002; 360: 1963–5.
27. Busse A, Bischkopf J, Riedel-Heller SG et al Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Br J Psych 2003; 182: 449–54.
28. Davis HS, Rockwood K. Conceptualization of mild cognitive impairment: a review. Int J Geriatr Psych 2004; 19: 313–9.
29. DeKeyser J, Herregodts P, Ebinger G. The mesoneocortical dopamine neuron system. Neurology 1990; 40: 1660–2.
30. DiCarlo A, Baldereschi M, Amaducci L et al Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Ger Soc 2000; 48: 775–82.
31. Dubois B, Verstichel P. Issues in diagnosis, therapeutic strategies and management of MCI disease in 2003. Results of international survey. MCI Forum 2003; 2: 1–11.
32. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical guidefor grading the mental state of patients for the clinician. J Psych Res 1975; 12: 189–98.
33. Frisoni GB, Galuzzi S, Bresciani L et al Mild cognitive impairment with subcortical vascular features. Clinical characteristics and outcome. J Neurol 2002; 249: 1423–32.
34. Golomb J, Kluger A, Garrard P, Ferris S. Clinician,s manual on mild cognitive impairment. London: Science Press, 2001.
35. Graham JE, Rockwood K, Beattie EL et al Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997; 349: 1793–6.
36. Hachinski V. Vascular dementia: a radical redefinition. In: Vascular dementia: Etiological, pathogenetic, clinical and treatment aspects. Ed. by L.A.Carlson, C.G.Gottfries, B.Winblad. Basel etc.: S.Karger, 1994; p. 2–4.
37. Hänninen T, Hallikainen M, Tuomainen S et al. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002; 106: 148–54.
38. Jelic V, Kivipelto M, Winblad B. Clinical trials of mild cognitive impairment: lessons for the future. J Neurol Neurosurg Psych 2006; 77 (Suppl. 7): 892.
39. Knopman DS, DeKosky ST, Cummings JL. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommitee of the American Academy of Neurology. Neurology 2001; 56: 1143–53.
40. Lindeboom J, Weinstein H. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol 2004; 490: 83–6.
41. Lezak MD. Neuropsychology assessment. N.Y. University Press. 1983; 768.
42. Lovenstone S, Gautier S. Management of dementia. London: Martin Dunitz, 2001.
43. Medical Information Letter on MCI. MCI Forum No 3. 2004.
44. Medical Information Letter on MCI. MCI Forum No 4. 2004.
45. Nagaraia D, Jayashree S. Randomised study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment. Am J Psychiat 2001; 158 (9): 1517–9.
46. Palmer K, Jelic V, Winblad B. Preface: mild cognitive impairment. Acta Neyrol Scand 2003; 107 (Suppl. 179): 5–6.
47. Petersen RS, Smith GE, Waring SC et al. Aging, memory and mild cognitive impairment. Int Psychogeriatr 1997; 9: 37–43.
48. Petersen RS, Smith GE, Waring SC et al Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303–8.
49. Petersen RC, Stevens JC, Ganguli M et al Practice parameter. Early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133–42.
50. Petersen RS, Touchon J. Consensus on mild cognitive impairment. Research and practice in Alzheimer's disease, E.A.D.C./A.D.C.S. Joint Meetihg 2005; 10: 24–32.
51. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56: 37–42.
52. Rockwood K, Wentzel C, Hachinski V et al Prevalence and outcomes of vascular cognitive impairment. Neurology 2000; 54 (2): 150–60.
53. Solfrizzi V, Panza F, Colacicco AM et al Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63: 1882–91.
54. Storandt M, Grant EA, Miller F et al Longitudinal course and neuropathologic outcomes in original vs revised MCI and pre-MCI. Neurology 2006; 67: 467–74.
55. Tian J, Bucks RS, Haworth J et al Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psych 2003; 74: 433–8.
56. Volkov ND, Logan J, Fowler JS et al Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiat 2000; 157 (1): 75–80.
57. Wahlund L-O, Pihlstrand E, Jonhagen ME. Mild cognitive impairment: expirience from a memory clinic. Acta Neurol Scand 2003; 107 (Suppl. 179): 21–4.
58. Wentzel C, Rockwood K, MacKnight C et al Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57 (4): 11–6.
59. Wolf H, Jelic V, Gertz H-J et al A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand 2003; 107 (Suppl. 179): 52–76.
60. Yesavage JA, O'Hara R, Kraemer H et al Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. J Psychiatr Res 2002; 36: 281–6.